-
Management Board: Highlights of June 2023 meeting
Management Board: Highlights of June 2023 meeting
-
Management Board: Highlights of June 2023 meeting
Management Board: Highlights of June 2023 meeting
The Board adopted the Executive Director’s annual activity report for 2022 and was updated on recent initiatives on clinical trials in the EU
-
Highlights of the Safety Committee: June 2023
Highlights of the Safety Committee: June 2023
-
Highlights of the Safety Committee: June 2023
Highlights of the Safety Committee: June 2023
At its monthly meeting, EMA's safety committee, the PRAC, carried out its work to assess all aspects of risk management related to the use of medicines
-
EMA-ECDC updates on adapted COVID-19 vaccines
EMA-ECDC updates on adapted COVID-19 vaccines
-
EMA-ECDC updates on adapted COVID-19 vaccines
EMA-ECDC updates on adapted COVID-19 vaccines
The European Centre for Disease Prevention and Control (ECDC) and EMA have issued a joint statement on adapted COVID-19 vaccines and their use in autumn vaccination campaigns
-
Adapting COVID-19 vaccines to future variants
Adapting COVID-19 vaccines to future variants
-
Adapting COVID-19 vaccines to future variants
Adapting COVID-19 vaccines to future variants
Global regulators agreed on a way forward to adapt COVID-19 vaccines to future variants, during a workshop co-chaired by EMA and the FDA, under the umbrella of ICMRA
Information for you
Key content
Services & databases
-
List item
Clinical Trials website
-
List item
Account Management portal
-
List item
eSubmission
-
List item
EudraVigilance (human)
-
List item
EudraVigilance Veterinary
-
List item
Veterinary Medicines information website
-
List item
Suspected adverse drug reactions database
-
List item
Clinical data
-
List item
SPOR data management services
-
List item
Service Desk
-
List item
IRIS platform
-
List item
Public register of parallel distribution notices
-
List item
European Vaccination Information Portal